Grant to investigate HSCs & innate immunity
Maziar Divangahi receives funding from the Bill & Melinda Gates Foundation.
Maziar Divangahi
View his faculty profile here: Maziar Divangahi, PhD
Associate Professor, Department of Medicine, McGill University
Associate Director, Meakins-Christie Laboratories
Research Theme: Host defense against pulmonary pathogens; regulation of death program in macrophages
Keywords: innate and adaptive immunity • influenza virus • mycobacterium tuberculosis • cell death program
View Maziar Divangahi’s recent posts and news below.
Meakins faculty delegation to Braunschweig
Meakins faculty visit the Helmholtz Centre for Infection Research in Braunschweig
Flu treatment using lipid target
Lipid mediator Leukotriene B4 is capable of reducing tissue damage from the flu
Anti-TB drugs can increase risk of TB re-infection
Vulnerability of the host to Mycobacterium tuberculosis infection is due to a compromised gut microbiota
Beyond Killing Tuberculosis
Publication by Maziar Divangahi and Nargis Khan in Science Immunology
Flu vaccine and immunotherapies
Meet RIPK3: a biological weapon to combat the flu
BCG-iv Induces Innate Immune Protection Against M. tuberculosis
Cell publication on how BCG induces innate immune protection against M. Tuberculosis
PGE2 inhibition increases survival of mice infected with H1N1 flu virus
New study by Maziar Divangahi show that PGE2 inhibition increases survival to the flu in mice
- « Previous
- 1
- 2
- 3